GlassScriptPhysician profile
Joseph H Altepeter
NPI 1013413426
$4,930.28
in general payments reported to CMS, 2019-2025
15 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $3,748 · 2023: $597 · 2024: $96.72 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,790.00 | 2022-2024 | |
| Aroa Biosurgery Incorporated | $255.49 | 2023 | |
| Medline Industries LP | $170.53 | 2021 | |
| Orthofix Medical, INC. | $146.53 | 2023 | Physio-Stim |
| Treace Medical Concepts, INC. | $107.04 | 2024-2025 | Tmc Psi Cut Guide System |
| Stryker Corporation | $82.85 | 2021-2025 | Prostep, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $80.88 | 2023-2025 | Nuzyra |
| Smith+Nephew, INC. | $75.69 | 2023-2025 | Collagenase Santyl, Regranex |
| Djo, LLC | $74.12 | 2023-2025 | Cmf |
| Convatec INC. | $40.55 | 2023 | |
| Solventum Corporation | $33.10 | 2025 | Activ.A.C. |
| Coastal Medical Technologies LLC | $24.97 | 2024 | |
| Abbvie INC. | $18.42 | 2023 | Dalvance |
| Cashflow Solutions, LLC | $15.80 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kci USA, INC. | $14.31 | 2023 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Altepeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.